AdvisorShares Psychedelics ETF (PSIL) News Today $12.66 -0.16 (-1.25%) Closing price 01/21/2025 04:10 PM EasternExtended Trading$12.46 -0.21 (-1.62%) As of 08:16 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartHoldingsOwnershipRatings All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period No Trippin’: Trump Trade Pushes PSIL, VCAR HigherNovember 15, 2024 | finance.yahoo.comDRUG Enhances Buzz for Psilocybin, Psychedelic ETFsOctober 18, 2024 | finance.yahoo.comAdvisorShares Psychedelics ETF (ARCA:PSIL), Short Interest ReportSeptember 12, 2024 | benzinga.comAdvisorShares Announces Reverse Split of ETFAugust 30, 2024 | finance.yahoo.comAdvisorShares Psychedelics ETFFebruary 13, 2024 | thestreet.comPsyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And MoreDecember 18, 2023 | markets.businessinsider.comPsyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And MoreSeptember 11, 2023 | markets.businessinsider.comPsyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly ReportsAugust 21, 2023 | benzinga.comPsyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & MoreJuly 24, 2023 | benzinga.comWatch these psychedelic stocks as sector faces year of 'collapse and consolidation'July 15, 2023 | msn.comPsyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And MoreJuly 11, 2023 | markets.businessinsider.comPsyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & MoreMay 15, 2023 | markets.businessinsider.comAre There Too Many ETFs?April 27, 2023 | thestreet.comFour Types of Nontraditional ETFsApril 26, 2023 | thestreet.comPsyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & MoreApril 17, 2023 | msn.comEXCLUSIVE: Investing In The Unique Growth Market Of PsychedelicsApril 13, 2023 | benzinga.comADVISORSHARES PSYCHEDELICS ETF (^PSIL-TC)March 28, 2023 | finance.yahoo.comPsyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & MoreMarch 7, 2023 | markets.businessinsider.comPsyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And MoreFebruary 27, 2023 | msn.comPSIL: When Investing In Psychedelic Firms, ETFs Are The Safer RouteFebruary 26, 2023 | seekingalpha.comMSOS AdvisorShares Pure US Cannabis ETFFebruary 18, 2023 | seekingalpha.comSCHD: ETF Inflow AlertJanuary 27, 2023 | nasdaq.comNervous About the Stock Market? 1 ETF to Keep Your Money SaferJanuary 25, 2023 | fool.comPsyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And MoreNovember 30, 2022 | markets.businessinsider.comPsyched: Top Psychedelics Execs., 50% Of Americans Support Medical Psychedelics, Cary Grant's LSD Therapy & MoreNovember 1, 2022 | benzinga.comPSIL AdvisorShares Psychedelics ETFSeptember 29, 2022 | seekingalpha.comAre Psychedelics Stocks In Trouble Or Is The Market Reaching Maturity?April 4, 2022 | markets.businessinsider.comDiversify Your Portfolio With a New Psychedelic Drug ETFFebruary 2, 2022 | entrepreneur.com3rd Psychedelics ETF LaunchesFebruary 2, 2022 | finance.yahoo.comNew thematic psychedelic ETF hits the marketFebruary 1, 2022 | seekingalpha.comFive niche ETFs that captured investor attention in 2021December 14, 2021 | theglobeandmail.comEnveric Biosciences Announces Inclusion in AdvisorShares Psychedelics ETFNovember 8, 2021 | finance.yahoo.comTryp Therapeutics Announces Inclusion in AdvisorShares Psychedelics ETFOctober 14, 2021 | finance.yahoo.comFinancialNewsMedia.com: Why North America Region is Dominating the Billion Dollar Psychedelic Drugs MarketOctober 5, 2021 | finanznachrichten.deWesana Health Announces Inclusion in the AdvisorShares Psychedelics ETFOctober 1, 2021 | finance.yahoo.comAdvisorShares Psychedelics ETF PSILSeptember 27, 2021 | morningstar.comAdvisorShares Psychedelics ETF (PSIL)September 25, 2021 | realmoney.thestreet.comMindset Pharma added to NYSE-listed AdvisorShares Psychedelics ETFSeptember 23, 2021 | proactiveinvestors.comMindset Pharma Announces Inclusion in NYSE Listed AdvisorShares Psychedelics Exchange Traded Fund (ETF)September 23, 2021 | finance.yahoo.comPsyched Wellness Announces Inclusion in AdvisorShares Psychedelics Exchange Traded Fund (ETF)September 22, 2021 | finance.yahoo.comMINDCURE Announces Inclusion in AdvisorShares Psychedelics ETFSeptember 22, 2021 | finance.yahoo.comRevive Therapeutics added to AdvisorShares Psychedelics ETFSeptember 21, 2021 | proactiveinvestors.comRevive Therapeutics Included in AdvisorShares® Newly Launched Psychedelics ETFSeptember 21, 2021 | finance.yahoo.comNovamind Inc.: Novamind Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETFSeptember 20, 2021 | finanznachrichten.deThe AdvisorShares Psychedelics ETF Officially Hits the MarketSeptember 20, 2021 | baystreet.caNovamind Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETFSeptember 20, 2021 | finance.yahoo.com Get AdvisorShares Psychedelics ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for PSIL and its competitors with MarketBeat's FREE daily newsletter. Email Address PSIL Media Mentions By Week PSIL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PSIL News Sentiment▼0.000.56▲Average News Sentiment PSIL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PSIL Articles This Week▼00▲PSIL Articles Average Week Get AdvisorShares Psychedelics ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for PSIL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VICE News Today JCTR News Today FFND News Today VERS News Today IDAT News Today SSPX News Today HECO News Today LITP News Today NIKL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEARCA:PSIL) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowPotential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share AdvisorShares Psychedelics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PSIL Stock Alerts